The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis
Titel:
The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis
Auteur:
Vaz Batista, Marta Pérez-García, José Manuel Garrigós, Laia García-Sáenz, José Ángel Cortez, Patricia Racca, Fabricio Blanch, Salvador Ruiz-Borrego, Manuel Fernández-Ortega, Adela Fernández-Abad, María Iranzo, Vega Gion, María Martrat, Griselda Alcalá-López, Daniel Pérez-Escuredo, Jhudit Sampayo-Cordero, Miguel Llombart-Cussac, Antonio Braga, Sofia Cortés, Javier